Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $707,787.00 |
|---|---|
| Enterprise Value | $11.99 Million |
| Earnings per Share | $-2.76 |
| Beta | 0.32 |
| Outstanding Shares | 29,491,125 |
| P/E Ratio | -0.01 |
|---|---|
| PEG | 0.01 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.98 |
| Enterprise Value to EBIT | -0.16 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 1.79 |
| Debt to Equity | 11.42 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
SQZ Biotechnologies is a clinical-stage biotechnology company developing transformative cell therapies for patients with cancer, infectious diseases, and other serious conditions. Using its proprietary technology, SQZ Biotechnologies off...